Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03966911 · ClinicalTrials.gov registry record · NA
Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 335
- Enrollment target
NCT03966911: Completed NA study, sponsored by Medtronic MiniMed.
NCT03966911 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 335 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03966911, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 335 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the performance of the Guardian™ Sensor (3) with an advanced algorithm in subjects age 2 - 80 years, for the span of 170 hours (7 days).
Interventions
- DEVICE Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2020-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03966911
The ClinicalTrials.gov registry entry for NCT03966911 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter is the first listed.
NCT03966911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03966911 about?
NCT03966911 is a clinical study titled "Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics". The purpose of this study is to demonstrate the performance of the Guardian™ Sensor (3) with an advanced algorithm in subjects age 2 - 80 years, for the span of 170 hours (7 days).
What is the current status of trial NCT03966911?
This trial is currently completed. It is a NA study. The enrollment target is 335 participants. The study started on 2019-06-14. Estimated completion is 2020-05-13.
What interventions are being tested in trial NCT03966911?
The interventions under investigation include: Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter (DEVICE).
Who is sponsoring clinical trial NCT03966911?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.